IBDEI0YT ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16970,1,4,0)
 ;;=4^Hernia
 ;;^UTILITY(U,$J,358.3,16971,0)
 ;;=533.90^^87^1030^4
 ;;^UTILITY(U,$J,358.3,16971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16971,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,16971,1,4,0)
 ;;=4^Peptic Ulcer Dis
 ;;^UTILITY(U,$J,358.3,16971,2)
 ;;=Peptic Ulcer Dis^93051
 ;;^UTILITY(U,$J,358.3,16972,0)
 ;;=571.5^^87^1031^4
 ;;^UTILITY(U,$J,358.3,16972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16972,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,16972,1,4,0)
 ;;=4^Cirrohosis
 ;;^UTILITY(U,$J,358.3,16973,0)
 ;;=790.6^^87^1031^1
 ;;^UTILITY(U,$J,358.3,16973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16973,1,3,0)
 ;;=3^790.6
 ;;^UTILITY(U,$J,358.3,16973,1,4,0)
 ;;=4^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,16973,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,16974,0)
 ;;=070.1^^87^1031^5
 ;;^UTILITY(U,$J,358.3,16974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16974,1,3,0)
 ;;=3^070.1
 ;;^UTILITY(U,$J,358.3,16974,1,4,0)
 ;;=4^Hepatitis A w/o Coma
 ;;^UTILITY(U,$J,358.3,16974,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,16975,0)
 ;;=070.30^^87^1031^6
 ;;^UTILITY(U,$J,358.3,16975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16975,1,3,0)
 ;;=3^070.30
 ;;^UTILITY(U,$J,358.3,16975,1,4,0)
 ;;=4^Hepatitis B w/o Coma or Delta
 ;;^UTILITY(U,$J,358.3,16975,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,16976,0)
 ;;=V02.62^^87^1031^7
 ;;^UTILITY(U,$J,358.3,16976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16976,1,3,0)
 ;;=3^V02.62
 ;;^UTILITY(U,$J,358.3,16976,1,4,0)
 ;;=4^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,16976,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,16977,0)
 ;;=070.51^^87^1031^2
 ;;^UTILITY(U,$J,358.3,16977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16977,1,3,0)
 ;;=3^070.51
 ;;^UTILITY(U,$J,358.3,16977,1,4,0)
 ;;=4^Acute Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,16977,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,16978,0)
 ;;=070.54^^87^1031^3
 ;;^UTILITY(U,$J,358.3,16978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16978,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,16978,1,4,0)
 ;;=4^Chr Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,16978,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,16979,0)
 ;;=070.70^^87^1031^8
 ;;^UTILITY(U,$J,358.3,16979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16979,1,3,0)
 ;;=3^070.70
 ;;^UTILITY(U,$J,358.3,16979,1,4,0)
 ;;=4^Hepatitis C w/o Coma,Unspec
 ;;^UTILITY(U,$J,358.3,16979,2)
 ;;=^331436
 ;;^UTILITY(U,$J,358.3,16980,0)
 ;;=340.^^87^1032^4
 ;;^UTILITY(U,$J,358.3,16980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16980,1,3,0)
 ;;=3^340.
 ;;^UTILITY(U,$J,358.3,16980,1,4,0)
 ;;=4^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,16981,0)
 ;;=435.9^^87^1032^6
 ;;^UTILITY(U,$J,358.3,16981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16981,1,3,0)
 ;;=3^435.9
 ;;^UTILITY(U,$J,358.3,16981,1,4,0)
 ;;=4^TIA
 ;;^UTILITY(U,$J,358.3,16982,0)
 ;;=356.9^^87^1032^5
 ;;^UTILITY(U,$J,358.3,16982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16982,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,16982,1,4,0)
 ;;=4^Periperal Neuropathy
 ;;^UTILITY(U,$J,358.3,16982,2)
 ;;=Peripheral Neuropathy^123931
 ;;^UTILITY(U,$J,358.3,16983,0)
 ;;=434.91^^87^1032^1
 ;;^UTILITY(U,$J,358.3,16983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16983,1,3,0)
 ;;=3^434.91
 ;;^UTILITY(U,$J,358.3,16983,1,4,0)
 ;;=4^Acute Stroke
 ;;^UTILITY(U,$J,358.3,16983,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,16984,0)
 ;;=V12.54^^87^1032^3
 ;;^UTILITY(U,$J,358.3,16984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16984,1,3,0)
 ;;=3^V12.54
 ;;^UTILITY(U,$J,358.3,16984,1,4,0)
 ;;=4^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,16984,2)
 ;;=^335309
 ;;
 ;;$END ROU IBDEI0YT
